Which IV drug tames a racing heart in AFib faster? a Head-to-Head trial

NCT ID NCT07706075

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This trial compares two standard IV medicines—verapamil and metoprolol—to see which controls rapid heart rate better in adults with atrial fibrillation who are otherwise stable. Patients receive one of the drugs in the emergency department, and their heart rate, blood pressure, and oxygen levels are monitored for 30 minutes. The goal is to find which drug works faster and more safely, helping doctors make evidence-based choices.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
intravenous verapamil or intravenous metoprolol
What this could lead to
If one drug works faster or more safely, it could help doctors choose the best treatment for atrial fibrillation with rapid heart rate in the emergency room.
What could go wrong
This is a small, single-center trial, so results may not apply to all patients. Both drugs can cause low blood pressure or slow heart rate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.